Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
Current assets
Cash and cash equivalents	$ 79,558	$ 57,526
Marketable securities	243,740	177,161
Accounts receivable	20,199	20,473
Prepaid expenses	10,776	9,067
Other current assets	19,479	13,774
Total current assets	373,752	278,001
Marketable securities	40,296	10,179
Accounts receivable	1,584	474
Property and equipment, net	111,017	117,589
Operating lease right-of-use assets	50,469	53,716
Restricted cash	2,030	2,030
Other assets	1,879	4,000
Total assets	581,027	465,989
Current liabilities
Accounts payable	21,655	22,798
Accrued expenses and other current liabilities	35,557	38,070
Deferred revenue	13,977	115
Operating lease liabilities	8,049	7,902
Royalty monetization liabilities	40,302	34,309
Total current liabilities	119,540	103,194
Deferred revenue	23,804
Operating lease liabilities	69,647	74,131
Royalty monetization liabilities	153,693	25,378
Other liabilities	664	3,635
Total liabilities	367,348	206,338
Stockholders’ equity
Preferred stock; $0.0001 par value; 10,000 shares authorized, no shares issued and outstanding at June 30, 2025 and December 31, 2024
Common stock; $0.0001 par value; 100,000 shares authorized at June 30, 2025 and December 31, 2024; 50,389 and 49,549 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively	5	5
Additional paid-in capital	1,211,361	1,192,536
Accumulated other comprehensive loss	(750)	(741)
Accumulated deficit	(996,937)	(932,149)
Total stockholders’ equity	213,679	259,651
Total liabilities and stockholders’ equity	$ 581,027	$ 465,989